1Govoni M, Castelllion G, Padovan M,et al. Recent advances and future perspective in neuroimagning in neuropsychiatric systemic lupus erythematosus. Lupus,2004,13: 149.
2Fredman SD,Stidley CA, Brooks WM,et al. Brain injury and neurometabolic abnormalities in systemic lupus erythematosus Radiology , 1998,209 : 79.
3Carreno I, Lopez-Longo FJ, Monteagudo I, et al. Immunological and olin cal differences juvenile and adult onset of systemic lupus erythematosus. Lupus,1999, 8: 287.
4Hanly JG. ACR classification criteria for systemic lupus erythematosus: limitations and revisions to neuropsychiatric variables. Lupus, 2004, 13:861.
1Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in SLE during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore),2003, 82: 299-308.
2Ainiala H, Loukkola J, Peltola J, et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology, 2001, 57: 496-500.
3Carreno L, Lopez-Longo FJ, Monteagudo I, et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus, 1999, 8: 287-292.
4Font J, Cervera R, Ramos-Casals M, et al. Clusters of clinical and immunologic features in systemic lupus erythematosus:analysis of 600 patients from a single center. Semin Arthritis Rheum,2004, 33: 217-230.
5Karassa FB, Ioannidis JP, Touloumi G, et al. Risk factors for central nervous system involvement in systemic lupus erythematosus. Q J Med, 2000, 93: 169-174.
6Tomita M, Khan RL, Blehm BH, et al. The potenOal pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus. Med Hypotheses, 2004, 62: 325-335.
7Janwityanuchit S, Verasertniyom O, Vanichapuntu M, et al. Anti-Sm:its predictive value in systemic lupus erythematosus. Clin Rheumatol, 1993, 12: 350-353.
8Reichlin M. Ribosomal P antibodies and CNS lupus. Lupus,2003, 12: 916-918.
9Afeltra A, Garzia P, Mitterhofer AP, et al. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibody. Neurology, 2003, 61: 108-110.
10Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients: the committee on prognosis studies in SLE. Arthritis Rheum, 1992, 35: 630-640.
4Zhou HQ,Zhang FC,Tian XP,et al.Clinical features and outcome of neuropsychiatric lupus in Chinese:analysis of 240 hospitalized patients.Lupus,2008,17(2):93-99.
5Omdal R,Waterlook,Koldingsnes W,et al.Somatic and psychological features of headache in systemic lupus erythematosus.J Rheumato1,2001,28 (4):772-779.
6Appenzeller S,Costallat LT.Clinical imlicationgs of migraine in systemic lupus etythematosus:relation to cumulative organ damage.Cephalalgia,2004,24 (12):1024-1030.
8Govoni M,Castelllion G,Padovan M,et al.Recent advances and future perspective in neuroimagning in neuropsychiatric systemic lupus erythematosus[J].Lupus,2004,13(3):149-158.
9Parodi A,Rebora A.ARA and EADV criteria for classification of systemic lupus erythematosus in patients with cutaneous lupus erythematosus[J].Dermatology,1997,194 (3):217-220.
10ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature.The american college of rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes[J].Arthritis Rheum,1999,42(4):599-608.
